What Will it Take to Build Global Regulatory Capacity?
Posted 22 October 2014 | By
The closing plenary of 2014 RAPS: The Regulatory Convergence in Austin, TX, featured a lively panel discussion about the importance of building regulatory capacity around the world, and how regulatory and healthcare leaders can go about building that capacity. The sessions touched on complexity and opportunity in global healthcare, themes that were repeated throughout the conference, which took place 27 September—1 October 2014.
Panelists were Martha Brumfield, PhD, from the Critical Path Institute; Mike Ward, Health Canada; Murray Lumpkin, MD, MSc, Bill & Melinda Gates Foundation: and John Lim of the Singapore Ministry of Health and Duke-National University of Singapore Graduate Medical School. RAPS Executive Director Sherry Keramidas, PhD, FASAE, CAE, moderated the panel.
View the entire discussion below. Note: the embedded video was recorded live at 2014 RAPS, and the opening includes some promotion of the 2015 RAPS Regulatory Convergence in Baltimore. The panel discussion begins just before the four-minute mark, so feel free to fast forward.